Total Funding
18
33
Total FundingSeries A raised
Growth Score 18 in past quarter
-8 pts
Heat Score 33 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
126982
Xperiome is a global healthtech company that delivers deep insights in rare disease experiences
Jeremy Edwards: CEOPast Role: Exco InTouch, Vice President of Business Development & General Manager
Nicki Grundy: CFOPast Role: Exco InTouch, Chief Financial Officer
About the Company
Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience. We created Raremark as the place for the lived experience of rare disease. This data-driven knowledge bank of the rare experience allows us to match research-ready members
to clinical and real-world studies, faster and smarter than ever before.